Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Xiamen C&D Corporation

Founders Liming Li

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 37
Average round size
info
The average size of a deal this fund participated in
$88M
Portfolio companies 34
Rounds per year 0.84
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.08
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Manufacturing
  • Pharmaceutical
  • E-Commerce
  • Biotechnology
Summary

In 1980 was created Xiamen C&D Corporation, which is appeared as Corporate Investor. The venture was found in Asia in China. The main department of described Corporate Investor is located in the Xiamen.

Among the various public portfolio startups of the fund, we may underline Microidea Technology, Yingsheng Biology, Skylimit Entertainment Group The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular fund investment industries, there are Health Care, Social Media.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Xiamen C&D Corporation, startups are often financed by ZhenFund, Yahui Precision Medicine Fund, Source Capital. The meaningful sponsors for the fund in investment in the same round are Shenzhen Weiyue Creative Investment Co., ZhenFund, Weibo. In the next rounds fund is usually obtained by Toutoushidao Capital, Shenzhen Weiyue Creative Investment Co., Qualcomm Ventures.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. The top activity for fund was in 2018. The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Xiamen C&D Corporation:
Typical Co-investors
Xiamen C&D Corporation is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Xiamen C&D Corporation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Background Capital -
CornerstoneCapital Frankfurt, Germany, Hessen
Fairfax Financial Holdings Canada, Ontario, Toronto
Fearless Ventures California, San Francisco, United States
INROADS Capital Partners Evanston, Illinois, United States
Jinkai High-tech Investment China, Japan, Kagoshima Prefecture
Jinyun Electrical Installation Beijing, Beijing, China
Lockheed Martin Bethesda, Maryland, United States
Morgan Creek Digital Chapel Hill, North Carolina, United States
Scytl Barcelona, Catalonia, Spain
Seed4Soft France, Ile-de-France, Paris
Strada Education Innovation Fund Indiana, Indianapolis, United States
Teton Growth Partners Jackson, United States, Wyoming
The Duke Endowment -
Unity Asset Management China, Shanghai
VCDE Venture Partners Frankfurt, Germany, Hessen
Watson Fund Seattle, United States, Washington

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Weijian Technology

Artificial Intelligence
Construction
Internet of Things
Robotics
$18M23 Aug 2024 Baoshan, Shanghai, China

Rongshujia

Health Care
Health Diagnostics
Medical
27 Mar 2024 Minhang, Shanghai, China

Cencorp Automation

$15M27 Oct 2023 Salo, Southwest Finland, Finland

Meiyi Automation

Industrial Automation
Sales Automation
Supply Chain Management
01 Sep 2023 Hangzhou, Zhejiang, China

Lattice Microelectronics

Electronics
20 Jun 2023 Yuhang, Zhejiang, China

Immorna

Biotechnology
Health Care
Medical
$13M27 Feb 2023 Hangzhou, Zhejiang, China

GenScript ProBio

Biopharma
Medical
Pharmaceutical
$220M18 Jan 2023 Nanjing, Jiangsu, China

Hyseim

Electronics
Industrial
$15M30 Dec 2022 Beijing, Beijing, China

VectorBuilder Inc

E-Commerce
Online Portals
$63M07 Oct 2022 Santa Clara, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Xiamen C&D Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 37
Average round size 88M
Rounds per year 0.84
Peak activity year 2023
Lead investments 6
Follow on index 0.08
Exits 1
Group Appearance index 0.89

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Weijian Technology

Artificial Intelligence
Construction
Internet of Things
Robotics
$18M23 Aug 2024 Baoshan, Shanghai, China

Rongshujia

Health Care
Health Diagnostics
Medical
27 Mar 2024 Minhang, Shanghai, China

Cencorp Automation

$15M27 Oct 2023 Salo, Southwest Finland, Finland

Meiyi Automation

Industrial Automation
Sales Automation
Supply Chain Management
01 Sep 2023 Hangzhou, Zhejiang, China

Lattice Microelectronics

Electronics
20 Jun 2023 Yuhang, Zhejiang, China

Immorna

Biotechnology
Health Care
Medical
$13M27 Feb 2023 Hangzhou, Zhejiang, China

GenScript ProBio

Biopharma
Medical
Pharmaceutical
$220M18 Jan 2023 Nanjing, Jiangsu, China

Hyseim

Electronics
Industrial
$15M30 Dec 2022 Beijing, Beijing, China

VectorBuilder Inc

E-Commerce
Online Portals
$63M07 Oct 2022 Santa Clara, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: